Patent US4724212A successfully refreshed from Google Patents.
US4724212A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Murine hybridoma Lym-2 and diagnostic antibody produced thereby
Assignee: Northwestern University
•
Filing: 1985-05-24
•
Granted: 1988-02-09
•
Expires: 2005-05-24
Abstract
Abstract Hybridoma Lym-2 (ATCC No. HB 8613) produces murine IgGl monoclonal antibodies specifically against normal human B cells and derived malignancies. The Lym-2 antibodies have possible clinical utility for the in vivo diagnosis of human B-cell lymphomas and leukemias.
Inventors
- 👤 Alan L. Epstein
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 08:33
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; C07K16/30; C07K16/3061; A; A61; A61K; A61K38/00
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
10 words
The hybridoma cell-line deposited under ATCC Accession No. HB 8613.
Claim 2
Dependent Claim
10 words
The hybridoma cell-line deposited under ATCC Accession No. HB 8613.
Claim 3
Dependent Claim
18 words
The monoclonal antibody produced by the hybridoma cell-line deposited under ATCC Accession No. HB 8613 and clones thereof.
Claim 4
Dependent Claim
18 words
The monoclonal antibody produced by the hybridoma cell-line deposited under ATCC Accession No. HB 8613 and clones thereof.
References Cited (Backward Citations)
US4513088A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-02-08 | 1991-08-10 | 1992-02-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-02-08 | 1995-08-10 | 1996-02-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-02-08 | 1999-08-10 | 2000-02-09 | $7700.00 | Window Closed / Lapsed |